Drug
Treprostinil Sustained Release
Treprostinil Sustained Release: highest development phase Phase 3, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Oral treprostinil (UT-15C) Sustained Release Tablets NCT00325403 | Phase 3 | Pulmonary Hypertension |
Latest
No recent events.
Follow Treprostinil Sustained Release on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.